<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03524079</url>
  </required_header>
  <id_info>
    <org_study_id>RV &amp; BrS</org_study_id>
    <nct_id>NCT03524079</nct_id>
  </id_info>
  <brief_title>Right Ventricle Morphology and Hemodynamics in BrS</brief_title>
  <acronym>RV-BrS</acronym>
  <official_title>Morphological and Functional Characteristics of the Right Ventricle in Patients With Brugada Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Donato</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Donato</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to evaluate the morphological and functional characteristics of the
      right ventricle before and after ajmaline in patients diagnosed with Brugada syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All consecutive patients with suspected BrS-ECG pattern will perform an ajmaline testing
      (1mg/kg in 5 min). A total of 30 patients with positive testing and 30 patients with negative
      testing will be selected and enrolled. Patients will perform cardiac magnetic resonance and
      3D echocardiography imaging to evaluate and compare morphological and functional
      characteristics of the 2 groups before and after ajmaline. Patients with positive testing
      will also perform a standardized programmed ventricular stimulation protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 19, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>echocardiographic parameters changes of the right and left ventricle function</measure>
    <time_frame>1 day during Echocardiography</time_frame>
    <description>Changes of right ejection fraction before and after ajmaline in Brugada patients as compared with control subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MRI changes of left and right ventricular function</measure>
    <time_frame>1day during MRI</time_frame>
    <description>MRI changes of left and right ventricular function before and after ajmaline in Brugada patients as compared with control subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>echocardiographic parameters changes of the right and left ventricle function</measure>
    <time_frame>1 day during Echocardiography</time_frame>
    <description>Changes of right ventricular areal strain before and after ajmaline in Brugada patients as compared with controls</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Brugada Syndrome</condition>
  <arm_group>
    <arm_group_label>BrS Group</arm_group_label>
    <description>Ajmaline 17-(Chloroacetate) Monohydrochloride</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No BrS group</arm_group_label>
    <description>Ajmaline 17-(Chloroacetate) Monohydrochloride</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ajmaline 17-(Chloroacetate) Monohydrochloride</intervention_name>
    <description>Ajmaline 17-(Chloroacetate) Monohydrochloride(1mg/kg in 5 minutes)</description>
    <arm_group_label>BrS Group</arm_group_label>
    <arm_group_label>No BrS group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 60 selected subjects (30 patients with positive ajmaline testing and 30 with
        negative testing) will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspicious Brugada syndrome

          -  Indication to ajmaline testing and programmed ventricular stimulation

          -  Age &gt; or equal to 18 years

          -  Written informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  Contraindication to CMRI or to ajmaline

          -  Live espectance &lt; 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Pappone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS San Donato University Hospital Policlinico San Donato, Milan, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlo Pappone, MD</last_name>
    <phone>02 527742287</phone>
    <email>carlo.pappone@af-ablation.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincenzo Santinelli, MD</last_name>
    <phone>+39 02 527742282</phone>
    <email>vincenzo.santinelli@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IRCCS Policlinico S. Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <state>Milano</state>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Pappone, MD, PhD</last_name>
      <phone>00390252774260</phone>
      <email>carlo.pappone@af-ablation.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>May 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <last_update_submitted>May 11, 2018</last_update_submitted>
  <last_update_submitted_qc>May 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Donato</investigator_affiliation>
    <investigator_full_name>Carlo Pappone</investigator_full_name>
    <investigator_title>Head of Arrhythmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Brugada Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ajmaline</mesh_term>
    <mesh_term>Lorajmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

